Skip to content
iCHOR
HOME
TECHNOLOGY
iSWEEP PLATFORM TECHNOLOGY
iART ARTERIAL SYSTEM
iDVT VENOUS SYSTEM
ABOUT
WHY iCHOR?
NEWS & EVENTS
INVESTORS
PATIENTS
CASE STUDIES
iCHOR in the News
FAQs
iCHOR Frequently Asked Questions
iCHOR Business and Market FAQs
CONTACT US
LOGIN

Author: iCHOR

07May

Dr Patrick Muck Presentation of iCHOR Vascular at the Pegasus Conference 2025

https://www.youtube.com/watch?v=VXmBaaOiYlY

Read more
27Feb

Ichor Vascular Commences Limited Market Release of 7-F Peripheral Reperfusion System

February 27, 2025—Ichor Vascular, Inc. announced the limited market release of its 7-F peripheral reperfusion system.In July 2024, the company announced FDA 510(k) clearance for the 7-F...

Read more
18Jul

Ichor Vascular’s 14-F Peripheral Reperfusion System Cleared by FDA

July 18, 2024—Ichor Vascular Inc. announced it has received FDA 510(k) clearance for the company’s 7-F peripheral reperfusion system, which is indicated for the nonsurgical...

Read more

Posts pagination

Prev 1 … 6 7 8 … 10 Next

SEARCH

Search for:

ABOUT iCHOR

iCHOR was founded by Interventional Radiologist Dr. Troy Long and industry veteran Tim Blair.  They identified an opportunity to develop new technologies to address these large unmet needs in treating peripheral vascular occlusions. This collaboration has lead to the development of the iSWEEP platform technology that has converted the tried and true Fogarty balloon sweep technique from an open surgery to a simple, minimally-invasive endovascular procedure.

iCHOR

P.O. Box 810787, 
Boca Raton, FL 33481

info@ichorvascular.com

HOME
TECHNOLOGY
iSWEEP PLATFORM
iART ARTERIAL SYSTEM
iDVT VENOUS SYSTEM
ABOUT
NEWS & EVENTS
WHY iCHOR?
INVESTORS
PATIENTS
CONTACT US

TRANSLATE

iCHOR Vascular © 2025     |     Terms of Use     |      Privacy